Alembic Limited Logo

Alembic Limited

ALEMBICLTD.NS

(2.2)
Stock Price

142,78 INR

10.09% ROA

15.6% ROE

10.52x PER

Market Cap.

24.073.312.406,00 INR

0.24% DER

2.35% Yield

168.14% NPM

Alembic Limited Stock Analysis

Alembic Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Alembic Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (17.11%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

With a remarkably low PBV ratio (0x), the stock offers substantial upside potential at a bargain price.

3 DER

The stock has a low debt to equity ratio (0%), which means it has a small amount of debt compared to the ownership it holds

4 Dividend

The company's consistent dividend payouts over the past five years exemplify its strong commitment to providing shareholders with reliable returns, making it an attractive investment option.

5 Dividend Growth

Investors can take confidence in the company's impressive track record of annual dividend growth over the last three years, showcasing a commitment to providing higher returns.

6 ROA

The stock's ROA (0%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

8 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

9 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

10 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (32) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Alembic Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Alembic Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Alembic Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Alembic Limited Revenue
Year Revenue Growth
2003 5.564.610.000
2004 5.244.581.000 -6.1%
2005 6.388.482.000 17.91%
2006 7.218.318.000 11.5%
2007 10.266.146.000 29.69%
2008 11.160.600.000 8.01%
2009 11.381.433.000 1.94%
2010 2.007.842.000 -466.85%
2011 14.663.874.000 86.31%
2012 1.792.155.000 -718.23%
2013 1.536.079.000 -16.67%
2014 1.443.275.000 -6.43%
2015 1.260.276.000 -14.52%
2016 1.345.741.000 6.35%
2017 1.194.901.000 -12.62%
2018 1.168.849.000 -2.23%
2019 672.550.000 -73.79%
2020 678.374.000 0.86%
2021 713.693.000 4.95%
2022 1.272.400.000 43.91%
2023 1.291.200.000 1.46%
2023 1.574.900.000 18.01%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Alembic Limited Research and Development Expenses
Year Research and Development Expenses Growth
2003 139.667.000
2004 167.550.000 16.64%
2005 198.889.000 15.76%
2006 227.576.000 12.61%
2007 433.885.000 47.55%
2008 403.000.000 -7.66%
2009 432.680.000 6.86%
2010 18.484.000 -2240.84%
2011 585.822.000 96.84%
2012 0 0%
2013 0 0%
2014 26.566.000 100%
2015 15.748.000 -68.69%
2016 6.659.000 -136.49%
2017 6.721.000 0.92%
2018 6.091.000 -10.34%
2019 1.486.000 -309.89%
2020 3.894.000 61.84%
2021 10.261.000 62.05%
2022 6.645.000 -54.42%
2023 0 0%
2023 1.006.000 100%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Alembic Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2003 538.541.000
2004 360.800.000 -49.26%
2005 531.916.000 32.17%
2006 533.034.000 0.21%
2007 711.202.000 25.05%
2008 0 0%
2009 778.161.000 100%
2010 0 0%
2011 932.606.000 100%
2012 5.305.000 -17479.75%
2013 8.666.000 38.78%
2014 0 0%
2015 28.264.000 100%
2016 30.540.000 7.45%
2017 28.633.000 -6.66%
2018 45.623.000 37.24%
2019 48.252.000 5.45%
2020 36.433.000 -32.44%
2021 63.602.000 42.72%
2022 55.061.000 -15.51%
2023 0 0%
2023 66.991.000 100%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Alembic Limited EBITDA
Year EBITDA Growth
2003 865.849.000
2004 933.923.000 7.29%
2005 1.209.192.000 22.76%
2006 1.459.233.000 17.14%
2007 1.802.376.000 19.04%
2008 950.200.000 -89.68%
2009 1.899.618.000 49.98%
2010 60.806.000 -3024.06%
2011 2.274.040.000 97.33%
2012 168.254.000 -1251.55%
2013 437.632.000 61.55%
2014 303.929.000 -43.99%
2015 317.577.000 4.3%
2016 361.654.000 12.19%
2017 386.192.000 6.35%
2018 463.182.000 16.62%
2019 947.364.000 51.11%
2020 184.249.000 -414.18%
2021 981.088.000 81.22%
2022 1.046.000.000 6.21%
2023 2.320.800.000 54.93%
2023 568.600.000 -308.16%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Alembic Limited Gross Profit
Year Gross Profit Growth
2003 5.544.544.000
2004 5.384.525.000 -2.97%
2005 6.597.880.000 18.39%
2006 7.015.546.000 5.95%
2007 10.455.364.000 32.9%
2008 5.649.000.000 -85.08%
2009 11.359.335.000 50.27%
2010 398.387.000 -2751.33%
2011 6.892.300.000 94.22%
2012 779.097.000 -784.65%
2013 933.187.000 16.51%
2014 685.512.000 -36.13%
2015 562.983.000 -21.76%
2016 354.463.000 -58.83%
2017 335.708.000 -5.59%
2018 404.796.000 17.07%
2019 286.570.000 -41.26%
2020 392.735.000 27.03%
2021 403.011.000 2.55%
2022 861.200.000 53.2%
2023 897.600.000 4.06%
2023 776.600.000 -15.58%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Alembic Limited Net Profit
Year Net Profit Growth
2003 312.587.000
2004 518.164.000 39.67%
2005 785.217.000 34.01%
2006 706.817.000 -11.09%
2007 1.121.925.000 37%
2008 108.200.000 -936.9%
2009 395.378.000 72.63%
2010 -129.019.000 406.45%
2011 1.301.326.000 109.91%
2012 114.934.000 -1032.24%
2013 295.270.000 61.07%
2014 241.487.000 -22.27%
2015 2.342.826.000 89.69%
2016 1.453.903.000 -61.14%
2017 1.629.790.000 10.79%
2018 2.131.038.000 23.52%
2019 3.291.179.000 35.25%
2020 3.428.448.000 4%
2021 2.220.590.000 -54.39%
2022 1.906.490.000 -16.48%
2023 3.627.200.000 47.44%
2023 2.686.191.000 -35.03%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Alembic Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2003 1
2004 2 0%
2005 3 50%
2006 3 0%
2007 4 50%
2008 0 0%
2009 1 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 1 100%
2014 4 66.67%
2015 9 62.5%
2016 5 -60%
2017 6 16.67%
2018 8 25%
2019 13 33.33%
2020 13 7.69%
2021 9 -62.5%
2022 7 -14.29%
2023 14 50%
2023 10 -40%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Alembic Limited Free Cashflow
Year Free Cashflow Growth
2003 660.190.000
2004 556.958.000 -18.53%
2005 413.551.000 -34.68%
2006 873.278.000 52.64%
2007 535.364.000 -63.12%
2008 1.230.941.000 56.51%
2009 1.490.928.000 17.44%
2010 32.846.000 -4439.15%
2011 794.843.000 95.87%
2012 769.978.000 -3.23%
2013 -108.241.000 811.36%
2014 217.561.000 149.75%
2015 341.993.000 36.38%
2016 373.065.000 8.33%
2017 -8.867.000 4307.34%
2018 -18.342.000 51.66%
2019 -161.813.000 88.66%
2020 -496.370.000 67.4%
2021 -535.601.000 7.32%
2022 130.300.000 511.05%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Alembic Limited Operating Cashflow
Year Operating Cashflow Growth
2003 660.190.000
2004 556.958.000 -18.53%
2005 413.551.000 -34.68%
2006 873.278.000 52.64%
2007 535.364.000 -63.12%
2008 1.230.941.000 56.51%
2009 1.490.928.000 17.44%
2010 134.645.000 -1007.3%
2011 1.407.406.000 90.43%
2012 801.894.000 -75.51%
2013 -102.272.000 884.08%
2014 219.584.000 146.58%
2015 345.600.000 36.46%
2016 516.263.000 33.06%
2017 235.769.000 -118.97%
2018 215.075.000 -9.62%
2019 61.729.000 -248.42%
2020 -21.817.000 382.94%
2021 -177.469.000 87.71%
2022 388.500.000 145.68%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Alembic Limited Capital Expenditure
Year Capital Expenditure Growth
2003 0
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 101.799.000 100%
2011 612.563.000 83.38%
2012 31.916.000 -1819.3%
2013 5.969.000 -434.7%
2014 2.023.000 -195.06%
2015 3.607.000 43.91%
2016 143.198.000 97.48%
2017 244.636.000 41.46%
2018 233.417.000 -4.81%
2019 223.542.000 -4.42%
2020 474.553.000 52.89%
2021 358.132.000 -32.51%
2022 258.200.000 -38.7%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Alembic Limited Equity
Year Equity Growth
2003 2.127.808.000
2004 2.736.630.000 22.25%
2005 3.362.319.000 18.61%
2006 3.849.183.000 12.65%
2007 3.413.654.000 -12.76%
2008 3.310.070.000 -3.13%
2009 3.372.862.000 1.86%
2010 2.093.660.000 -61.1%
2011 3.949.984.000 47%
2012 2.058.355.000 -91.9%
2013 2.306.765.000 10.77%
2014 2.642.299.000 12.7%
2015 7.403.938.000 64.31%
2016 9.114.357.000 18.77%
2017 10.857.736.000 16.06%
2018 12.085.286.000 10.16%
2019 14.180.418.000 14.77%
2020 22.970.281.000 38.27%
2021 24.965.833.000 7.99%
2022 20.780.400.000 -20.14%
2023 21.196.600.000 1.96%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Alembic Limited Assets
Year Assets Growth
2003 5.580.952.000
2004 6.225.248.000 10.35%
2005 6.821.119.000 8.74%
2006 8.852.161.000 22.94%
2007 9.458.480.000 6.41%
2008 10.152.532.000 6.84%
2009 9.966.957.000 -1.86%
2010 3.385.743.000 -194.38%
2011 10.519.041.000 67.81%
2012 3.439.829.000 -205.8%
2013 3.561.556.000 3.42%
2014 3.574.523.000 0.36%
2015 8.010.321.000 55.38%
2016 9.923.781.000 19.28%
2017 11.590.487.000 14.38%
2018 12.658.487.000 8.44%
2019 14.707.201.000 13.93%
2020 24.089.619.000 38.95%
2021 26.319.528.000 8.47%
2022 22.045.800.000 -19.39%
2023 22.697.200.000 2.87%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Alembic Limited Liabilities
Year Liabilities Growth
2003 3.453.144.000
2004 3.488.618.000 1.02%
2005 3.458.800.000 -0.86%
2006 5.002.978.000 30.87%
2007 6.044.826.000 17.24%
2008 6.842.462.000 11.66%
2009 6.594.095.000 -3.77%
2010 1.292.083.000 -410.35%
2011 6.569.057.000 80.33%
2012 1.381.474.000 -375.51%
2013 1.254.791.000 -10.1%
2014 932.224.000 -34.6%
2015 606.383.000 -53.74%
2016 809.424.000 25.08%
2017 732.751.000 -10.46%
2018 573.201.000 -27.83%
2019 526.783.000 -8.81%
2020 1.119.338.000 52.94%
2021 1.353.695.000 17.31%
2022 1.265.400.000 -6.98%
2023 1.500.600.000 15.67%

Alembic Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
5.33
Net Income per Share
8.91
Price to Earning Ratio
10.52x
Price To Sales Ratio
17.59x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
1.14
EV to Sales
17.62
EV Over EBITDA
27
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.1
FreeCashFlow Yield
0
Market Cap
24,07 Bil.
Enterprise Value
24,10 Bil.
Graham Number
128.63
Graham NetNet
-2.88

Income Statement Metrics

Net Income per Share
8.91
Income Quality
0
ROE
0.22
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
3
EBT Per Ebit
1.02
Ebit per Revenue
0.55
Effective Tax Rate
0.06

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.67
Operating Profit Margin
0.55
Pretax Profit Margin
0.56
Net Profit Margin
1.68

Dividends

Dividend Yield
0.02
Dividend Yield %
2.35
Payout Ratio
0
Dividend Per Share
2.2

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.04
Return on Tangible Assets
0.1
Days Sales Outstanding
62.2
Days Payables Outstanding
249.98
Days of Inventory on Hand
724.97
Receivables Turnover
5.87
Payables Turnover
1.46
Inventory Turnover
0.5
Capex per Share
0

Balance Sheet

Cash per Share
0,60
Book Value per Share
82,51
Tangible Book Value per Share
82.51
Shareholders Equity per Share
82.51
Interest Debt per Share
0.21
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.03
Current Ratio
1.4
Tangible Asset Value
21,20 Bil.
Net Current Asset Value
-0,10 Bil.
Invested Capital
0
Working Capital
0,40 Bil.
Intangibles to Total Assets
0
Average Receivables
0,12 Bil.
Average Payables
0,15 Bil.
Average Inventory
432700000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Alembic Limited Dividends
Year Dividends Growth
2002 5
2003 5 0%
2004 2 -100%
2005 3 33.33%
2006 5 40%
2007 1 -400%
2008 2 0%
2009 0 0%
2010 1 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 1 0%
2021 0 0%
2022 2 100%
2023 2 50%

Alembic Limited Profile

About Alembic Limited

Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition, it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. The company also exports its products. Alembic Limited was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Limited.

CEO
Ms. Malika Chirayu Amin
Employee
271
Address
Alembic Road
Vadodara, 390003

Alembic Limited Executives & BODs

Alembic Limited Executives & BODs
# Name Age
1 Mr. Keval Thakkar
Company Secretary & Compliance Officer
70
2 Ms. Malika Chirayu Amin
MD, Chief Executive Officer & Executive Director
70
3 Mr. Rasesh Shah
Chief Financial Officer
70

Alembic Limited Competitors

Balmer Lawrie & Co. Ltd. Logo
Balmer Lawrie & Co. Ltd.

BALMLAWRIE.NS

(3.2)
Aarti Drugs Limited Logo
Aarti Drugs Limited

AARTIDRUGS.NS

(2.0)
Bliss GVS Pharma Limited Logo
Bliss GVS Pharma Limited

BLISSGVS.NS

(3.2)
Caplin Point Laboratories Limited Logo
Caplin Point Laboratories Limited

CAPLIPOINT.NS

(4.2)